IQVIA Holdings Inc (NYSE:IQV) — Market Cap & Net Worth
Market Cap & Net Worth: IQVIA Holdings Inc (IQV)
IQVIA Holdings Inc (NYSE:IQV) has a market capitalization of $26.76 Billion ($26.76 Billion) as of May 2, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #979 globally and #410 in its home market, demonstrating a -1.81% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying IQVIA Holdings Inc's stock price $157.77 by its total outstanding shares 169600000 (169.60 Million). Analyse cash flow conversion of IQVIA Holdings Inc to see how efficiently the company converts income to cash.
IQVIA Holdings Inc Market Cap History: 2015 to 2026
IQVIA Holdings Inc's market capitalization history from 2015 to 2026. Data shows growth from $11.64 Billion to $26.76 Billion (7.76% CAGR).
Index Memberships
IQVIA Holdings Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$59.46 Trillion | 0.05% | #306 of 503 |
Weight: IQVIA Holdings Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
IQVIA Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how IQVIA Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.34x
IQVIA Holdings Inc's market cap is 2.34 times its annual revenue
Latest Price to Earnings (P/E) Ratio
28.11x
IQVIA Holdings Inc's market cap is 28.11 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $12.90 Billion | $6.82 Billion | $115.00 Million | 1.89x | 112.16x |
| 2017 | $16.60 Billion | $9.70 Billion | $1.31 Billion | 1.71x | 12.68x |
| 2018 | $19.70 Billion | $10.41 Billion | $259.00 Million | 1.89x | 76.07x |
| 2019 | $26.20 Billion | $11.09 Billion | $191.00 Million | 2.36x | 137.20x |
| 2020 | $30.39 Billion | $11.36 Billion | $279.00 Million | 2.68x | 108.91x |
| 2021 | $47.85 Billion | $13.87 Billion | $966.00 Million | 3.45x | 49.54x |
| 2022 | $34.75 Billion | $14.41 Billion | $1.09 Billion | 2.41x | 31.85x |
| 2023 | $39.24 Billion | $14.98 Billion | $1.36 Billion | 2.62x | 28.90x |
| 2024 | $33.33 Billion | $15.40 Billion | $1.37 Billion | 2.16x | 24.27x |
| 2025 | $38.23 Billion | $16.31 Billion | $1.36 Billion | 2.34x | 28.11x |
Competitor Companies of IQV by Market Capitalization
Companies near IQVIA Holdings Inc in the global market cap rankings as of May 2, 2026.
Key companies related to IQVIA Holdings Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #126 globally with a market cap of $176.29 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $123.72 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #578 globally with a market cap of $45.31 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #643 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.29 Billion | $469.21 |
| #189 | Danaher Corporation | NYSE:DHR | $123.72 Billion | $175.15 |
| #578 | IDEXX Laboratories Inc | NASDAQ:IDXX | $45.31 Billion | $567.46 |
| #643 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
IQVIA Holdings Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, IQVIA Holdings Inc's market cap moved from $11.64 Billion to $ 26.76 Billion, with a yearly change of 7.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $26.76 Billion | -30.01% |
| 2025 | $38.23 Billion | +14.71% |
| 2024 | $33.33 Billion | -15.07% |
| 2023 | $39.24 Billion | +12.93% |
| 2022 | $34.75 Billion | -27.38% |
| 2021 | $47.85 Billion | +57.47% |
| 2020 | $30.39 Billion | +15.96% |
| 2019 | $26.20 Billion | +33.00% |
| 2018 | $19.70 Billion | +18.66% |
| 2017 | $16.60 Billion | +28.73% |
| 2016 | $12.90 Billion | +10.76% |
| 2015 | $11.64 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of IQVIA Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $26.76 Billion USD |
| MoneyControl | $26.76 Billion USD |
| MarketWatch | $26.76 Billion USD |
| marketcap.company | $26.76 Billion USD |
| Reuters | $26.76 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About IQVIA Holdings Inc
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment of… Read more